Effectiveness of Ashwagandha (Withania somnifera (L.) Dunal) In The Management Of Vishaada (Mild To Moderate Depressive Disorder) Among Adolescents: A Randomized Double Blind Placebo Controlled Trial

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年2月21日

试验速览

暂无简介。

•Participants showing signs of Mild to Moderate Depression as per DSM-V Criteria. (PHQ-9 score 5-14).
•Participants providing written informed consent of caretakers/parents.
•Participants providing written informed assent to participate in the study.

•No Depression (PHQ- 9 score below or equals to 4) along with no other clinical manifestation.
•Severe Depression (PHQ- 9 score equal or above 15).
•Intelligent Quotient (IQ) Below 70 [Borderline Intelligence].
•Any severe co-morbid psychiatric disorder, especially a diagnosis of bipolar disorder, schizophrenia, autism spectrum disorder, schizoaffective disorder or organic psychiatric disorder assessed by taking detailed history and examination.
•Any other medical or neurological conditions or any other illness interfering with interventions.
•Participants suffering from any systemic illness, history of epilepsy or chronic illness like hypo or hyperthyroidism.
•Substance use disorder or dependency, suicidal ideations.
•Current use of Anti-epileptics, anti-psychotic or psychotropic drugs (e.g., Selective Serotonin Reuptake Inhibitor, Serotonin and norepinephrine reuptake inhibitors etc.) and any other investigational drugs

发起方